Close Menu

BioReference Laboratories

With students and faculty scheduled to return in a few months, institutions are reaching out to secure testing to help keep the virus in check on campus.

Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.

High-profile groups have proposed population-scale testing as key to a safe reopening, but the test numbers they propose dwarf current and projected lab capacity.

News items for the in vitro diagnostics industry for the week of May 18, 2020.

BioReference will provide administrative services, laboratory equipment, supplies, and procurement processes for the hospital.

The company's revenues for its 4Kscore prostate cancer test were impacted partially by the COVID-19 pandemic, Opko said.

A number of labs have said that not only are they able to fulfill all current PCR test requests, but that they are operating at below capacity for these tests.

Of the 28 companies in the index, 27 firms saw their stock prices increase, while one firm's share price decreased slightly.

With clinical labs suffering large drops in volumes as patients stay away from draw centers, remote sampling could provide a way to offer routine testing.